Paper6290
Studies on the centrally mediated hypotensive activity of guanabenz.
Baum T and 1 other. Eur J Pharmacol, 1976. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Studies on the centrally mediated hypotensive activity of guanabenz. Papers, record 6290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Pressure | Major topic |
| Guanabenz | Major topic |
| Guanidines | Major topic |
| Adrenergic alpha-Antagonists | |
| Animals | |
| Carotid Sinus | |
| Cats | |
| Denervation | |
| Depression, Chemical | |
| Electric Stimulation | |
| Female | |
| Ganglia, Spinal | |
| Hypothalamus | |
| Male | |
| Pressoreceptors |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41619089 | The discovery of monoamine oxidase inhibitors: virtual screening and in vitro inhibition potencies. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/41619089 | PubMed |
| 35820743 | Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35820743 | PubMed |
| 33410111 | Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling. | Neurotherapeutics | 2021 | https://conductscience.org/library/papers/33410111 | PubMed |
| 33168944 | Guanabenz modulates microglia and macrophages during demyelination. | Sci Rep | 2020 | https://conductscience.org/library/papers/33168944 | PubMed |
| 26873788 | Harnessing the integrated stress response for the treatment of multiple sclerosis. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/26873788 | PubMed |
| 26696956 | Remyelination Therapy in Multiple Sclerosis. | Front Neurol | 2015 | https://conductscience.org/library/papers/26696956 | PubMed |
| 26303803 | Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26303803 | PubMed |
| 25766071 | Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. | Nat Commun | 2015 | https://conductscience.org/library/papers/25766071 | PubMed |
| 8564219 | Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/8564219 | PubMed |
| 6352237 | Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. | Drugs | 1983 | https://conductscience.org/library/papers/6352237 | PubMed |
| 6135165 | The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with alpha 2-adrenoceptor agonistic properties. | Naunyn Schmiedebergs Arch Pharmacol | 1983 | https://conductscience.org/library/papers/6135165 | PubMed |
| 3736681 | Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz. | Naunyn Schmiedebergs Arch Pharmacol | 1986 | https://conductscience.org/library/papers/3736681 | PubMed |
| 26908 | A basis for migraine therapy- the autonomic theory reappraised. | Postgrad Med J | 1978 | https://conductscience.org/library/papers/26908 | PubMed |
| 22821 | Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type". | Naunyn Schmiedebergs Arch Pharmacol | 1977 | https://conductscience.org/library/papers/22821 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6290
GET https://conductscience.org/api/papers/v1/6290/authors